BCVA: gain of 15 or more ETDRS letters · proliferative diabetic retinopathy
It is very uncertain whether nd:YAG laser changes BCVA: gain of 15 or more ETDRS letters compared with argon‐green laser (very low certainty).
1 finding from 1 review
BCVA: loss of 15 or more ETDRS letters · proliferative diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
BCVA: gain of 15 or more ETDRS letters · proliferative diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
BCVA: loss of 15 or more ETDRS letters · proliferative diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
BCVA: gain of 15 or more ETDRS letters · proliferative diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Loss of ≥ 15 letters BCVA at 1 year · proliferative diabetic retinopathy
Central PRP showed no clear difference in BCVA: loss of 15 or more ETDRS letters ‐ 1 year compared with peripheral PRP (low certainty).
1 finding from 1 review
BCVA: gain of 15 or more ETDRS letters · proliferative diabetic retinopathy
Central PRP showed no clear difference in BCVA: gain of 15 or more ETDRS letters ‐ 1 year compared with peripheral PRP (low certainty).
1 finding from 1 review
BCVA: loss of 15 or more ETDRS letters · proliferative diabetic retinopathy
Centre sparing PRP showed no clear difference in BCVA: loss of 15 or more ETDRS letters compared with full scatter PRP (low certainty).
1 finding from 1 review
BCVA: gain of 15 or more ETDRS letters · proliferative diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
BCVA: loss of 15 or more ETDRS letters · people with diabetic retinopathy
Extended targeted PRP showed no clear difference in BCVA: loss of 15 or more ETDRS letters: compared with standard PRP (low certainty).
1 finding from 1 review
BCVA: gain of 15 or more ETDRS letters · people with diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
BCVA: loss of 15 or more ETDRS letters · proliferative diabetic retinopathy
It is very uncertain whether diode laser changes BCVA: loss of 15 or more ETDRS letters compared with argon laser (very low certainty).
1 finding from 1 review
BCVA: gain of 15 or more ETDRS letters · proliferative diabetic retinopathy
It is very uncertain whether diode laser changes BCVA: gain of 15 or more ETDRS letters compared with argon laser (very low certainty).
1 finding from 1 review
Intervention not reported
Proportion of participants who lost two or more lines of best‐corrected visual acuity (BCVA) · participants aged 18‐60 years with myopia ranging in severity up to 12 diopters (D)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
or more recurrences of retinochoroiditis · People with toxoplasma retinochoroiditis
Antibiotic probably leads to lower or more recurrences of retinochoroiditis compared with no treatment (moderate certainty).
1 finding from 1 review
Intervention not reported
Loss of 1 or more lines of BSCVA at 12 months post treatment · adult participants (≥ 18 years) with myopia
It is very uncertain whether the intervention changes loss of 1 or more lines of BSCVA at 12 months post treatment (very low certainty).
1 finding from 1 review
RR 3 [0.13, 71.96]
Studies not reported
Very low
Intervention not reported
Adverse outcomes ‐ corneal haze score at 12 months (grade 1.0 ‐ more prominent haze that does not interfere with visibility of fine iris details; grade 2.0 ‐ mild obscuration of iris details; grade 3.0 ‐ moderate obscuration of iris and lens; and ... · adult participants (≥ 18 years) with myopia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Visual loss of 2‐3+ lines of visual acuity · wound healing in glaucoma surgery
MMC showed no clear difference in loss of 2 or more lines of Snellen visual acuity at 1 year compared with 5‐FU (low certainty).
1 finding from 1 review
Proportion using one or more medications at one year after surgery Number of participants · patients with eyes with cataract and glaucoma
Combined surgery may leads to lower proportion using one or more medications at one year after surgery… compared with phacoemulsification alone (low certainty).
1 finding from 1 review
Change in visual loss associated with PSR: visual loss is defined by the deterioration of visual acuity of 3 lines or more with the Snellen chart · people with AMD
Omega 3 fatty acids probably leads to higher loss of 3 or more lines of VA at 24 months compared with placebo (moderate certainty).
2 findings from 1 review